Viewing Study NCT01705002

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-02-02 @ 4:17 PM
Study NCT ID: NCT01705002
Status: COMPLETED
Last Update Posted: 2018-07-10
First Post: 2012-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.
Sponsor: Lipomedix Pharmaceuticals Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Solid Tumor View
None Metastatic Colorectal Cancer (mCRC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None phase 1 View
None dose escalating View
None prodrug View
None mitomycin C View
None Capecitabine View